Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.6997
+0.0005 (0.07%)
At close: Aug 28, 2026, 4:00 PM EDT
0.6997
0.00 (0.00%)
After-hours: Aug 28, 2026, 4:10 PM EDT
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $23.28 million as of August 28, 2026. Its market cap has decreased by -50.60% in one year.
Market Cap
23.28M
Enterprise Value
16.24M
1-Year Change
-50.60%
Ranking
Category
Stock Price
$0.70
ChartMarket Cap Chart
Since January 10, 2020, Jasper Therapeutics's market cap has decreased from $122.75M to $23.28M, a decrease of -81.03%. That is a compound annual growth rate of -22.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 23.28M | -54.54% |
| Dec 31, 2025 | 51.21M | -84.03% |
| Dec 31, 2024 | 320.73M | 264.33% |
| Dec 29, 2023 | 88.03M | 294.73% |
| Dec 30, 2022 | 22.30M | -94.26% |
| Dec 31, 2021 | 388.71M | 210.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 24.34M |
| Tvardi Therapeutics | 24.01M |
| Cellectar Biosciences | 24.01M |
| Polyrizon | 23.96M |
| Cerenome | 23.53M |
| Genenta Science | 23.37M |
| Dyadic International | 23.29M |
| Niki BioSolutions | 22.16M |